also found similar results in their study of 27 ganglioneuroma and neuroblastoma tumor specimens: PSA-NCAM expression was highest in patients with undifferentiated neuroblastoma and advanced stages of disease, while differentiated tumors and low clinical stages had distinctly reduced to no PSA-NCAM expression (25). This evidence concerns the gene NCAM1 and neoplasm.